Meet Your Host
Jeff Galvin, CEO
Jeff Galvin is a visionary biotech leader and entrepreneur committed to pioneering revolutionary gene and cell therapies. He is the founder and CEO of American Gene Technologies (AGT), a leading company focused on the development of potential cures for infectious diseases, cancers, and rare genetic disorders. Galvin also established Addimmune, an AGT subsidiary dedicated entirely to pursuing a functional cure for HIV.
Jeff Galvin graduated from Harvard University with a BA in Economics. His career began in Silicon Valley as a software engineer for Hewlett Packard. From HP it was on to Apple, then Blyth Software, then Claris Software, then Argus Software. Galvin’s entrepreneurial spirit quickly emerged, leading him to establish various successful tech startups, even venturing into the medical technology space with a company later acquired by Varian, a prominent manufacturer of cancer therapy equipment. A stint as an angel investor, with interests in real estate and technology, further broadened his experience.
About Us
The Cure Chronicles delves deep into the stories of those at the forefront of ending HIV. From groundbreaking researchers to the bravest advocates, hear how a future without HIV could look, directly from those leading the way. At Addimmune, we’re not just imagining a world without HIV—we’re creating it. Our cutting-edge gene therapy research aims to offer a cure within our lifetimes, transforming lives around the globe.
Also Available On
Our podcast content is also available on the following platforms: